List of Tables
Table 1. Global Bevacizumab Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Bevacizumab Injection Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Bevacizumab Injection Market Competitive Situation by Manufacturers in 2024
Table 4. Global Bevacizumab Injection Sales (K Doses) of Key Manufacturers (2020-2025)
Table 5. Global Bevacizumab Injection Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Bevacizumab Injection Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Bevacizumab Injection Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Bevacizumab Injection Average Price (US$/Dose) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Bevacizumab Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Bevacizumab Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Bevacizumab Injection, Product Type & Application
Table 12. Global Key Manufacturers of Bevacizumab Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Bevacizumab Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bevacizumab Injection as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Bevacizumab Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Bevacizumab Injection Sales by Region (2020-2025) & (K Doses)
Table 18. Global Bevacizumab Injection Sales Market Share by Region (2020-2025)
Table 19. Global Bevacizumab Injection Sales by Region (2026-2031) & (K Doses)
Table 20. Global Bevacizumab Injection Sales Market Share by Region (2026-2031)
Table 21. Global Bevacizumab Injection Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Bevacizumab Injection Revenue Market Share by Region (2020-2025)
Table 23. Global Bevacizumab Injection Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Bevacizumab Injection Revenue Market Share by Region (2026-2031)
Table 25. North America Bevacizumab Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Bevacizumab Injection Sales by Country (2020-2025) & (K Doses)
Table 27. North America Bevacizumab Injection Sales by Country (2026-2031) & (K Doses)
Table 28. North America Bevacizumab Injection Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Bevacizumab Injection Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Bevacizumab Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Bevacizumab Injection Sales by Country (2020-2025) & (K Doses)
Table 32. Europe Bevacizumab Injection Sales by Country (2026-2031) & (K Doses)
Table 33. Europe Bevacizumab Injection Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Bevacizumab Injection Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Bevacizumab Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Bevacizumab Injection Sales by Region (2020-2025) & (K Doses)
Table 37. Asia Pacific Bevacizumab Injection Sales by Region (2026-2031) & (K Doses)
Table 38. Asia Pacific Bevacizumab Injection Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Bevacizumab Injection Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Bevacizumab Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Bevacizumab Injection Sales by Country (2020-2025) & (K Doses)
Table 42. Latin America Bevacizumab Injection Sales by Country (2026-2031) & (K Doses)
Table 43. Latin America Bevacizumab Injection Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Bevacizumab Injection Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Bevacizumab Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Bevacizumab Injection Sales by Country (2020-2025) & (K Doses)
Table 47. Middle East and Africa Bevacizumab Injection Sales by Country (2026-2031) & (K Doses)
Table 48. Middle East and Africa Bevacizumab Injection Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Bevacizumab Injection Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Bevacizumab Injection Sales (K Doses) by Type (2020-2025)
Table 51. Global Bevacizumab Injection Sales (K Doses) by Type (2026-2031)
Table 52. Global Bevacizumab Injection Sales Market Share by Type (2020-2025)
Table 53. Global Bevacizumab Injection Sales Market Share by Type (2026-2031)
Table 54. Global Bevacizumab Injection Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Bevacizumab Injection Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Bevacizumab Injection Revenue Market Share by Type (2020-2025)
Table 57. Global Bevacizumab Injection Revenue Market Share by Type (2026-2031)
Table 58. Global Bevacizumab Injection Price (US$/Dose) by Type (2020-2025)
Table 59. Global Bevacizumab Injection Price (US$/Dose) by Type (2026-2031)
Table 60. Global Bevacizumab Injection Sales (K Doses) by Application (2020-2025)
Table 61. Global Bevacizumab Injection Sales (K Doses) by Application (2026-2031)
Table 62. Global Bevacizumab Injection Sales Market Share by Application (2020-2025)
Table 63. Global Bevacizumab Injection Sales Market Share by Application (2026-2031)
Table 64. Global Bevacizumab Injection Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Bevacizumab Injection Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Bevacizumab Injection Revenue Market Share by Application (2020-2025)
Table 67. Global Bevacizumab Injection Revenue Market Share by Application (2026-2031)
Table 68. Global Bevacizumab Injection Price (US$/Dose) by Application (2020-2025)
Table 69. Global Bevacizumab Injection Price (US$/Dose) by Application (2026-2031)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Bevacizumab Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 73. Pfizer Bevacizumab Injection Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Roche Company Information
Table 76. Roche Description and Business Overview
Table 77. Roche Bevacizumab Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 78. Roche Bevacizumab Injection Product
Table 79. Roche Recent Developments/Updates
Table 80. Eli Lilly Company Information
Table 81. Eli Lilly Description and Business Overview
Table 82. Eli Lilly Bevacizumab Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 83. Eli Lilly Bevacizumab Injection Product
Table 84. Eli Lilly Recent Developments/Updates
Table 85. Genentech Company Information
Table 86. Genentech Description and Business Overview
Table 87. Genentech Bevacizumab Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 88. Genentech Bevacizumab Injection Product
Table 89. Genentech Recent Developments/Updates
Table 90. Bayer Company Information
Table 91. Bayer Description and Business Overview
Table 92. Bayer Bevacizumab Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 93. Bayer Bevacizumab Injection Product
Table 94. Bayer Recent Developments/Updates
Table 95. Amgen Company Information
Table 96. Amgen Description and Business Overview
Table 97. Amgen Bevacizumab Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 98. Amgen Bevacizumab Injection Product
Table 99. Amgen Recent Developments/Updates
Table 100. Samsung Bioepis Company Information
Table 101. Samsung Bioepis Description and Business Overview
Table 102. Samsung Bioepis Bevacizumab Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 103. Samsung Bioepis Bevacizumab Injection Product
Table 104. Samsung Bioepis Recent Developments/Updates
Table 105. Centus Company Information
Table 106. Centus Description and Business Overview
Table 107. Centus Bevacizumab Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 108. Centus Bevacizumab Injection Product
Table 109. Centus Recent Developments/Updates
Table 110. Cadila Pharmaceuticals Company Information
Table 111. Cadila Pharmaceuticals Description and Business Overview
Table 112. Cadila Pharmaceuticals Bevacizumab Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 113. Cadila Pharmaceuticals Bevacizumab Injection Product
Table 114. Cadila Pharmaceuticals Recent Developments/Updates
Table 115. Dr Reddy's Company Information
Table 116. Dr Reddy's Description and Business Overview
Table 117. Dr Reddy's Bevacizumab Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 118. Dr Reddy's Bevacizumab Injection Product
Table 119. Dr Reddy's Recent Developments/Updates
Table 120. Mylan Company Information
Table 121. Mylan Description and Business Overview
Table 122. Mylan Bevacizumab Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 123. Mylan Bevacizumab Injection Product
Table 124. Mylan Recent Developments/Updates
Table 125. Hetero Group Company Information
Table 126. Hetero Group Description and Business Overview
Table 127. Hetero Group Bevacizumab Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 128. Hetero Group Bevacizumab Injection Product
Table 129. Hetero Group Recent Developments/Updates
Table 130. Biocon Company Information
Table 131. Biocon Description and Business Overview
Table 132. Biocon Bevacizumab Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 133. Biocon Bevacizumab Injection Product
Table 134. Biocon Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Bevacizumab Injection Distributors List
Table 138. Bevacizumab Injection Customers List
Table 139. Bevacizumab Injection Market Trends
Table 140. Bevacizumab Injection Market Drivers
Table 141. Bevacizumab Injection Market Challenges
Table 142. Bevacizumab Injection Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Bevacizumab Injection
Figure 2. Global Bevacizumab Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Bevacizumab Injection Market Share by Type: 2024 & 2031
Figure 4. 100mg Product Picture
Figure 5. 400mg Product Picture
Figure 6. Global Bevacizumab Injection Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Bevacizumab Injection Market Share by Application: 2024 & 2031
Figure 8. Age-related macular degeneration (AMD)
Figure 9. Ovarian Cancer
Figure 10. Others
Figure 11. Global Bevacizumab Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Bevacizumab Injection Market Size (2020-2031) & (US$ Million)
Figure 13. Global Bevacizumab Injection Sales (2020-2031) & (K Doses)
Figure 14. Global Bevacizumab Injection Average Price (US$/Dose) & (2020-2031)
Figure 15. Bevacizumab Injection Report Years Considered
Figure 16. Bevacizumab Injection Sales Share by Manufacturers in 2024
Figure 17. Global Bevacizumab Injection Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Bevacizumab Injection Players: Market Share by Revenue in Bevacizumab Injection in 2024
Figure 19. Bevacizumab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Bevacizumab Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Bevacizumab Injection Sales Market Share by Country (2020-2031)
Figure 22. North America Bevacizumab Injection Revenue Market Share by Country (2020-2031)
Figure 23. United States Bevacizumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Bevacizumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Bevacizumab Injection Sales Market Share by Country (2020-2031)
Figure 26. Europe Bevacizumab Injection Revenue Market Share by Country (2020-2031)
Figure 27. Germany Bevacizumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Bevacizumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Bevacizumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Bevacizumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Bevacizumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Bevacizumab Injection Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Bevacizumab Injection Revenue Market Share by Region (2020-2031)
Figure 34. China Bevacizumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Bevacizumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Bevacizumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Bevacizumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Bevacizumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Bevacizumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Bevacizumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Bevacizumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Bevacizumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Bevacizumab Injection Sales Market Share by Country (2020-2031)
Figure 44. Latin America Bevacizumab Injection Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Bevacizumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Bevacizumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Bevacizumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Bevacizumab Injection Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Bevacizumab Injection Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Bevacizumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Bevacizumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Bevacizumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Bevacizumab Injection by Type (2020-2031)
Figure 54. Global Revenue Market Share of Bevacizumab Injection by Type (2020-2031)
Figure 55. Global Bevacizumab Injection Price (US$/Dose) by Type (2020-2031)
Figure 56. Global Sales Market Share of Bevacizumab Injection by Application (2020-2031)
Figure 57. Global Revenue Market Share of Bevacizumab Injection by Application (2020-2031)
Figure 58. Global Bevacizumab Injection Price (US$/Dose) by Application (2020-2031)
Figure 59. Bevacizumab Injection Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
